
Availability of multi-level omics data such as genome, transcriptome, proteome and phosphatome data enables system-level analyses for the prediction and characterization of selective drug response on target diseases.
Integration of multi-level omics data with chemical or siRNA screening data on diverse biological samples is accelerating discovery studies on clinically relevant drug applications and their mode of actions.
For this purpose, we have constructed a smart screening platform combining technologies on computer-oriented big data mining and experimental high content screening for last several years.
 Method development and optimization for big data analysis
  Method development and optimization for big data analysis  Generate diverse patterns and hypotheses describing the association between varied drug
 Generate diverse patterns and hypotheses describing the association between varied drug  Validation of target molecules and samples for the optimization of high content siRNA or
 Validation of target molecules and samples for the optimization of high content siRNA or   
 Image and cell-based assay development for high content screening
  Image and cell-based assay development for high content screening   Automation and standardization of high throughput screening
  Automation and standardization of high throughput screening   System-level interpretation of siRNA library screening
  System-level interpretation of siRNA library screening   Application of machine learning algorithms for cell-based SAR studies
  Application of machine learning algorithms for cell-based SAR studies   3D shape-based chemical analysis
  3D shape-based chemical analysis   Protein and peptide sequence optimization
   Protein and peptide sequence optimization  